OOIR: Observatory of International Research

Papers

(The H4-Index of Cardiovascular Research is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
The backstage of the Russian–Ukrainian war: refugees in urgent need of cardiovascular management	382
Inhibition of novel lipoprotein(a) receptor major facilitator superfamily domain containing 5 (MFSD5) reduces development of aortic valve calcification	294
Inflammation-induced arterial dysfunction in atherosclerosis; the modulating action of mesenchymal stem cell-derived extracellular vesicles	214
In vivo calcium and voltage mapping of the zebrafish heart	200
Blockers of Hyperpolarization-activated Cyclic Nucleotide-gated channels exhibit antimuscarinic properties in human atrial cardiomyocytes	169
Novel ex-vivo calcification model for human aortic valves reveals patient-specific effect of compound	163
Clinical Case 08—A challenging clinical case: acute limb ischemia as a presentation of a left ventricular thrombus in a patient with heart failure with reduced ejection fraction	153
Timing of capillary enlargement after adenoviral VEGF gene transfer does not support post-ischemic skeletal muscle recovery in hyperlipidemic mice	145
FABP4 as potential indicator for GDM-induced fetal endothelial dysfunction	142
Exogenous Growth Differentiation Factor 15 (GDF15) exerts direct cardioprotective properties towards myocardial ischemia reperfusion injury	133
Hypoxic preconditioning effects change in hypertrophied or insulin resistant rat hearts	132
Increased oxidative stress alters coronary microvascular tone in exercising swine with multiple comorbidities	127
Investigating the cardiotoxicity of particulate matter air pollution using a mouse model	122
Oral Presentation No. 019 Bi-directional cross talk between coagulation, fibrinolysis and inflammatory pathways in patients with ST-segment elevation myocardial infarction	117
Elderberry extract inhibits tumour necrosis factor induced monocyte adhesion to endothelial cells via modulation of the NF-κB pathway	114
The mechanistic role of connexin 43 in maturation of hiPSC cardiomyocytes	112
Impaired autophagy mechanisms associated with phospholamban-R14del disease	105
Micromanaging atherosclerosis: myeloid cell-specific microRNA-26b attenuates atherosclerosis development	102
Poster No. 106 Can we optimize d-dimer cut off value to predict pulmonary embolism in covid-19 patients?	96
Clinical Case 18—Management of patient with cancer and confirmed systemic thrombosis and rectal bleeding	93
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity	91
Corrigendum to: CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression	89
Accelerating developments in heart failure	87
Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence	85
Elevated soluble ST2 and in-hospital mortality in patients with type A aortic dissection	83

PRDM16, a new kid on the block in cardiovascular health and disease	81
Cardioprotection in cardio-oncology: a case for concern?	79
Rapamycin reduces atherosclerotic plaque inflammation in aged mice	74
The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis	73
Defining HFpEF in rodents: a systematic review	73
ChemR23 signalling as a potential therapeutic target in atherosclerosis and cardiovascular diseases	71
Early biomarkers of disease in hypertrophic cardiomyopathy: does telomere length matter?	68
Propafenone as potential AgoKir: exploration of long-term effects and mechanisms of propafenone on Kir2.1 channel	68
Telomerase and myocardin co-expressing mesenchymal cells increase survival and induce cardiac and vascular markers in cardiac stromal cells undergoing simulated ischemia/reperfusion	65
Matrix metalloproteinase-3 joins a growing list of proteases that regulate vascular calcification	61
Cardioprotective MicroRNA (ProtectomiRs) identified in a porcine model of acute myocardial infarction and ischemic conditioning: in vitro validation of novel candidates	61
EZH2 controls microRNA expression in T cells in atherosclerosis	60
MiRNA-19b targets mineralocorticoid receptor and prevents calcification of female valve interstitial cells	60
Inhibition of dysregulated il-8-cxcr1 paracrine cellular crosstalk reverses cardiac hypertrophy and fibrosis in noonan syndrome	59
Low levels of endothelial nitric oxide synthase (eNOS) might serve as a potential indicator for recurrent atrial fibrillation	58
The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies	57
Endothelial Rho kinase controls blood vessel integrity and angiogenesis	57
SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?	57
Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes	56
Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase	56
TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells	56
Should we resurrect acetazolamide as a diuretic for congestion due to heart failure?	55
Aircraft noise exposure induces pro-inflammatory vascular conditioning and amplifies vascular dysfunction and impairment of cardiac function after myocardial infarction	55
Circulating dimethylguanidino valeric acid, dietary factors, and risk of coronary heart disease	55
Corrigendum to: Transient stabilization of human cardiovascular progenitor cells from human pluripotent stem cells in vitro reflects stage-specific heart development in vivo	52
MiR-92b-3p modulates apoptosis in smooth muscle cells through BCL2L11 regulation, unravelling novel therapeutic strategies for unstable plaques	50
Keep your guard up: blood–brain barrier protection by empagliflozin after acute ischaemic stroke	50